SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,602,000 | +1136.6% | 32,970 | +731.7% | 0.19% | +1500.0% |
| Q4 2019 | $453,000 | +30.9% | 3,964 | -2.1% | 0.01% | 0.0% |
| Q3 2019 | $346,000 | +9.8% | 4,050 | -0.3% | 0.01% | 0.0% |
| Q2 2019 | $315,000 | +0.6% | 4,064 | -4.8% | 0.01% | -7.7% |
| Q1 2019 | $313,000 | +8.7% | 4,270 | +14.2% | 0.01% | +18.2% |
| Q3 2018 | $288,000 | +25.8% | 3,738 | +8.3% | 0.01% | +10.0% |
| Q2 2018 | $229,000 | -26.4% | 3,451 | -39.6% | 0.01% | -41.2% |
| Q3 2017 | $311,000 | +10.7% | 5,714 | +5.3% | 0.02% | 0.0% |
| Q2 2017 | $281,000 | +6.4% | 5,427 | +29.0% | 0.02% | 0.0% |
| Q1 2017 | $264,000 | +23.4% | 4,207 | +3.5% | 0.02% | +6.2% |
| Q4 2016 | $214,000 | – | 4,064 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |